|
Volumn 14, Issue 5, 2005, Pages 425-
|
Rationale for the use of trastuzumab in patients with cerebral metastases who previously receive trastuzumab-based therapy for metastatic breast cancer
e
NONE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
TRASTUZUMAB;
APOPTOSIS;
BLOOD BRAIN BARRIER;
BRAIN CAPILLARY;
BRAIN METASTASIS;
BREAST CANCER;
CANCER CELL CULTURE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
LETTER;
MEMBRANE DAMAGE;
METASTASIS POTENTIAL;
MOLECULAR WEIGHT;
PRIORITY JOURNAL;
RADIATION INJURY;
RADIOSENSITIVITY;
|
EID: 27144470510
PISSN: 09609776
EISSN: None
Source Type: Journal
DOI: 10.1016/j.breast.2004.08.016 Document Type: Letter |
Times cited : (6)
|
References (8)
|